Combinatorial drug therapy for cancer in the post-genomic era

Cited by (999)

Items 801–900 of 999

1. Identifying Synergistic Components of Botanical Fungicide Formulations Using Interpretable Graph Neural Networks
   Oliver Snow, Amirreza Kazemi, Forum Bhanshali, Alyas Nasiri, Annett Rozek, Martin Ester · 2024 · Journal of Chemical Information and Modeling
2. Compartment Model and Neural Network-Based Analysis of Combination Medication Ratios
   Yuxin Zeng, Jieyu Yang, Yong Li · 2025 · Pharmaceutics
3. Combined Effects of Curcumin and Carboplatin on Mitochondrial Depolarization and Caspase Activation in Human Lung Adenocarcinoma Cells
   Yüksel Öğünç Keçeci, Mine Ezer Oktay, Zerrin İncesu, Filiz Özdemir · 2025 · Anti-Cancer Agents in Medicinal Chemistry
4. MADSP: predicting anti-cancer drug synergy through multi-source integration and attention-based representation learning
   Yuqi Hong, Qichang Zhao, Jianxin Wang · 2025 · Bioinformatics
5. AACDR: Integrating Graph Isomorphism Networks and Asymmetric Adversarial Domain Adaptation for Cancer Drug Response Prediction
   Yi Zhang, Ting-Fang Wu, Liang-Peng Nie, Ye-Lu Jiang, Geng Li, Jia Xu, Zhenglong Zhou, Yiwei Chen, Li-Jun Quan, Qiang Lyu · 2025 · Journal of Chemical Information and Modeling
6. GraphFusion: Integrative prediction of drug synergy using multi-scale graph representations and cell line contexts
   Biyang Zeng, Shikui Tu, Lei Xu · 2025 · Journal of Biomedical Informatics
7. GLA-Synergy: An Interpretable Global-Local Adaptive Framework for Drug Synergy Prediction in Cancer Treatment
   Lizhi Deng, Shiyu Yan, Jiaoxing Yang, Mingyong Li, Pingjian Ding · 2025 · Journal of Chemical Information and Modeling
8. ACF-01 enhances the anticancer effect of doxorubicin by suppressing stemness and inducing apoptosis in triple-negative breast cancer stem-like cells
   Sun Hee Yang, Ji Soo Kim, Dae Kyeong Kim, Tae Hyeon Yoon, Moonjae Cho, Somi Kim Cho · 2025 · Applied Biological Chemistry
9. BridgeSyn: a bridging fusion framework for drug combination synergy prediction
   Qingyu Wang, Suwan Mao, Xiaoyan Liu, Quan Zou, Qing Liu, Xi Su, Junjie Wang, Wen Gao, Ximei Luo · 2025 · Briefings in Bioinformatics
10. On-Chip Prediction of Combination Drug Efficacy Using a Magnetofluidic Platform with Integrated Capacitive Sensors
    Vinit Kumar Yadav, Preetha Ganguly, Samaresh Das, Prashant Mishra, Dhiman Mallick · 2025 · ACS Applied Materials & Interfaces
11. Ratiometric Strategies in Oncology: Multifunctional Roles in Chemotherapy, Imaging, and Diagnosis
    Pooja Khade, Ujala Gupta, Neelesh Kumar Mehra, Pankaj Kumar Singh · 2025 · ACS Applied Bio Materials
12. From Biology to Bedside: Challenges and Strategies in Developing Combination Cancer Therapies in Early-Phase Trials
    Niamh Coleman, Robert Donald Harvey, David S. Hong, Patricia Mucci LoRusso · 2026 · Clinical Cancer Research
13. The application of experimental models for the drug discovery for digestive tumors
    Linxiao Zheng, Wen Shuai, Yinyang Liu, Yang Deng, Ji Bao, Xiuying Hu, Guan Wang · 2026 · Molecular Cancer
14. GraFSyn: An Interpretable Deep Learning Framework for Anticancer Drug Synergy via Graphlet Fingerprints
    Wei Xia, Yayu Tian, Shiyu Zhou, Huanhuan Du, Mingchen Xiao, Zhuxu Ge, Xuan He · 2026 · Journal of Chemical Information and Modeling
15. Molecular Targets in Cancer Therapy
    Anand Shankar Ramteke, Suresh Kumar Ramakrishnan, Rajesh Agarwal · 2025 · Springer eBooks
16. Disentangled Representations of Cellular Identity
    Ziheng Wang, Grace Hui Ting Yeo, Richard I. Sherwood, David Kenneth Gifford · 2019 · Lecture notes in computer science
17. A multi-task graph convolutional network modeling of drug-drug interactions and synergistic efficacy
    Yuanyuan Deng, Song Yu, Lei Deng, Hui Liu, Xuejun Liu, Yi Ping Luo · 2021 · IEEE International Conference on Bioinformatics and Biomedicine (BIBM)
18. SİNERJİSTİK İLAÇ KOMBİNASYONLARININ ANALİZİNDE GÜNCEL MATEMATİKSEL VE İSTATİSTİKSEL YÖNTEMLER
    Bayram Oğuz ÖZER · 2023 · Ankara Universitesi Eczacilik Fakultesi Dergisi
19. Novel highly effective combination of naturally-derived quercetin and ascorbyl palmitate and their nanoformulations as an advancement therapy of cancer
    Mohamed El-Far, Alaa Essam, Fardous F. El‐Senduny, Amira O. Abd El‐Azim, Sarah Yahia, Ibrahim mohammed El-sherbiny · 2023 · Journal of Drug Delivery Science and Technology
20. A análise patentométrica como subsídio à gestão da inovação tecnológica: um estudo de caso em radiofármacos para câncer
    Henrique Koch Chaves, Júlia Maria Brandão da Silva, Carla Cristina De Freitas da Silveira, Fabio Luiz Navarro Marques, Jorge Lima de Magalhães · 2023 · Encontros Bibli Revista Eletrônica de Biblioteconomia e Ciência da Informação
21. Production and development of novel drug targets through AI
    Ghada Abd‐Elmonsef Mahmoud, Omnia Karem M. Riad, Mona Shaban E. M. Badawy · 2024 · Methods in microbiology
22. Computer-Aided Identification and Design of Ligands for Multi-Targeting Inhibition of a Molecular Acute Myeloid Leukemia Network
    Seyedehsadaf Asfa, Reza Arshinchi Bonab, Onur Önder, Merve Uca, Hatice Döşeme, Can Küçük, Alexandros G. Georgakilas, Bernhard M. Stadler, Stella Logotheti, Seyit Kale et al. · 2024 · Cancers
23. Low-Dose Perifosine, a Phase II Phospholipid Akt Inhibitor, Selectively Sensitizes Drug-Resistant ABCB1-Overexpressing Cancer Cells
    Jae Hyeon Park, Haeun Lee, Tian Zheng, Joo Kyung Shin, Sungpil Yoon, Hyung Sik Kim · 2024 · Biomolecules & Therapeutics
24. Self‐Assembly of Antisense DNA‐Camptothecin Amphiphile into Glutathione‐Responsive Nanoparticles for Combination Cancer Therapy
    Anusree Krishna, Anupama Babulal, Mareena Sajeev, Nirmal Ravi, Gowtham Raj, Anitta Antony, Nikhil Dev Narendradev, Srinivasa Murty Srinivasula, Reji Varghese · 2025 · Chemistry - A European Journal
25. pH-Triggered delivery of pirarubicin–gemcitabine duo using polymeric nanoparticles for synergistic breast cancer therapy
    Priya Gupta, Harshdeep Kaur, Anees Mohammad, Sachchidanand Tiwari, Ankushi Bansal, Harpal Singh · 2025 · Nanoscale Horizons
26. Tetrahydroquinoline/4,5-dihydroisoxazoline hybrids counteracts multidrug resistance by inhibiting MRP1-mediated drug efflux
    Giovana da Silva Pereira, Luis C. Vesga, Gustavo Scheiffer, Ingrid Fátima Zattoni, Bruna Estelita Ruginsk, Cristian C. Bernal, Arnold R. Romero Bohórquez, Stelia C. Méndez‐Sánchez, Azam Rashidian, Antti Poso et al. · 2025 · Biochemical and Biophysical Research Communications
27. One-hot news: drug synergy models shortcut molecular features
    Emine Beyza Candir, Halil İbrahim Kuru, Magnus Rattray, A. Ercüment Çiçek, Öznur Taştan · 2026 · Bioinformatics
28. The Role of Proteomics in Personalized Medicine
    Djuro Josić, Uroš Andjelković · 2016 · Europeanization and globalization
29. A multifunctional toolkit for target-directed cancer therapy
    Montserrat Terrazas, Dani Sánchez, Federica Battistini, Núria Villegas, Isabelle Brun Heath, Modesto Orozco · 2018 · Chemical Communications
30. Scaling Out a Combinatorial Algorithm for Discovering Carcinogenic Gene Combinations to Thousands of GPUs
    Sajal Dash, Qais Al hajri, Wu-chun Feng, Harold R. Garner, Ramu Anandakrishnan · 2021 · IEEE International Parallel and Distributed Processing Symposium (IPDPS)
31. Enhancing access to innovative cancer drugs: Cross-sector consensus on a way forward to benefit patients
    Richard Hoey, Eva Sharpe, Angela K Kukula, Paul Workman · 2021 · Drug Discovery Today
32. Synergistic Effects of Methotrexate and Suberoylanilide Hydroxamic Acid in Triggering Apoptosis of Chronic Myeloid Leukemia Cells
    YALÇIN, AHMET SUHA, Ayşe Mine Yılmaz · 2015 · International Journal of Hematology and Oncology
33. Combination of T-DM1 and platinum-based chemotherapy in patient-derived xenograft models of muscle-invasive bladder cancer.
    Abolfazl Razzaghdoust, Samad Muhammadnejad, Mahmoud Parvin, Bahram Bahram, Masoumeh Zangeneh, Abbas Basiri · 2022 · PubMed Central
34. ADVANCEMENTS IN CANCER PHARMACOTHERAPY: TARGETED THERAPIES AND IMMUNOTHERAPY STRATEGIES, A REVIEW
    Hina Maqbool, U YASIN, L SHAWAL, Fariha Zulfiqar, N FATIMA, Wiaam M Hasan, H NASIM, M ISMAIL, MA RAFIQ · 2024 · Biological and Clinical Sciences Research Journal
35. Artocarpus altilis CG-901 alters critical nodes in the JH1-kinase domain of Janus kinase 2 affecting upstream JAK/STAT3 signaling
    Oyekanmi Nash, Olaposi Idowu Omotuyi, Joonku Lee, Byoung‐Mog Kwon, Lucy Ogbadu · 2015 · Journal of Molecular Modeling
36. [Synergistic drug combination prediction in multi-input neural network].
    Xi Chen, Yufang Qin, Ming Chen, Chongyang Zhang · 2020 · PubMed Central
37. Combinational treatments for breast cancer
    Mahsa Rasekhian, Omid Tavallaei, Marzieh Marzbany · 2020 · Journal of Reports in Pharmaceutical Sciences
38. Drug-Resistant Cancer Treatment Strategies Based on the Dynamics of Clonal Evolution and PKPD Modeling of Drug Combinations
    Vahideh Vakil, Wade K. Trappe · 2020 · IEEE Transactions on Computational Biology and Bioinformatics
39. Challenges in combining novel molecularly targeted agents in cancer medicine
    Timothy Anthony Yap · 2014 · Annals of Oncology
40. Optimization and control of large-scale networked systems
    Neil K. Dhingra · 2017 · University of Minnesota Digital Conservancy (University of Minnesota)
41. A reference model for the combination of an arbitrary number of drugs: A generalization of the Bliss independence model
    Wim De Mulder, Martin T. R. Kuiper, Åsmund Flobak · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
42. References
    2018 · Wiley eBooks
43. Combination Therapy Case Studies in Anticancer and Anti‐Infectious Disease Drug Discovery and Development
    Xianhai Huang, David Yu‐Kai Chen · 2022
44. Patient-derived tumoroids of advanced high-grade neuroendocrine neoplasms mimic patient chemotherapy responses and guide the design of personalized combination therapies
    Simon April-Monn, Katharina M Detjen, Philipp Kirchner, Konstantin Bräutigam, Mafalda A. Trippel, Tobias J. Grob, Cyril Statzer, Renaud Maire, Attila Kollár, Aziz Chouchane et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
45. Natural Language Processing Charts Transcriptome Evolution to Design Combination Cancer Therapies
    Amir Jassim, Birgit V. Nimmervoll, Sabrina Terranova, Erica Nathan, Katherine Elizabeth Masih, Lisa Ruff, Matilde Duarte, Elizabeth Alexandra Cooper, Linda Hu, Gunjan Katyal et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
46. Systems Perturbation Analysis of a Large-Scale Signal Transduction Model Reveals Potentially Influential Candidates for Cancer Therapeutics
    Bhanwar Lal Puniya, Laura Allen, Colleen G. Hochfelder, Mahbubul Majumder, Tomáš Helikar · 2016 · Frontiers in Bioengineering and Biotechnology
47. Toll-like receptor structural determinants: Variability analysis by digital signal processing methods
    Norbert Maggi, Patrizio Arrigo, C. Ruggiero · 2013 · IEEE International Conference on Bioinformatics and Bioengineering (BIBE)
48. Vehicles for Delivery of Therapeutic Agent for Cancer Therapy
    Ramakant Joshi, Rajendra Chauhan, Wasim Akram, Pawan Kushwah, Hemant Mourya, Navneet Garud · 2023 · Biological and medical physics, biomedical engineering
49. DC-FMDT: A Fuzzy Model Decision Tree Algorithm Based on Drug Combination Features
    Jing Chen · 2023 · International Conference on Computer Engineering and Application (ICCEA)
50. A low-cost machine learning framework for predicting drug–drug interactions based on fusion of multiple features and a parameter self-tuning strategy
    Zexiao Liang, Canxin Lin, Guoliang Tan, Jianzhong Li, Yan Zhong He, Shuting Cai · 2024 · Physical Chemistry Chemical Physics
51. Mainstreaming Ayurveda Rasayana (rejuvenation) therapy for maintaining health and avoiding disease recurrence
    Dhirajsingh Sumersingh Rajput · 2024 · Journal of Indian System of Medicine
52. A weighted Bayesian integration method for predicting drug combination using heterogeneous data
    Tingting Li, Long Xiao, Haigang Geng, An‐Qi Chen, Yue‐Qing Hu · 2024 · Journal of Translational Medicine
53. PKCα Activation via the Thyroid Hormone Membrane Receptor Is Key to Thyroid Cancer Growth
    Mateo N. Campos Haedo, Johanna Abigail Díaz Albuja, Sandra Camarero, Florencia Cayrol, Helena Sterle, Mercedes Debernardi, Marina Perona, Melina Sabán, Glenda Ernst, Julián Mendez et al. · 2024 · International Journal of Molecular Sciences
54. The emerging role of Sotorasib plus Panitumumab combination therapy in colorectal cancer treatment
    Emmanuel Kokori, Gbolahan Deji Olatunji, Ikponmwosa Jude Ogieuhi, Yusuf Ismaila Ajayi, Olumide Damilola Akinmoju, Adeola Akinboade, Jessy Grantay Irumudomon, Oluwatobi Taiwo Omoworare, Chimezirim Ezeano, Yewande Abigail Adebayo et al. · 2025 · International Journal of Clinical Oncology
55. Recent developments in 3D printing pharmaceutical, bioprinting and implant for tissue engineering formulations
    Ranjitsinh Pawar, Ankeeta Sankapall, Mayur Samal, Vaishnavi Sadaphal, Sabeeha Mohiudin, Mangesh Sangale · 2025 · Journal of Biomaterials Science Polymer Edition
56. Optimal Designs for Order-of-Addition Two-Level Factorial Experiments
    Qiang Zhao, Qian Xiao, Abhyuday Mandal, Fasheng Sun · 2025 · Technometrics
57. CADS: Causal Inference for Dissecting Essential Genes to Predict Drug Synergy
    Huaiwu Zhang, Jing Ping Tang · 2025 · Lecture notes in computer science
58. NPCDR 2.0: the activity and structure landscape of natural product-based drug combination
    Quan Gao, Xinyuan Yu, Kaixuan Liu, Zhiyu Zhu, Mengting Chen, Zhao Xiaohong, Zehua Liao, Lihui Xu, Ying Zhou, Feng Zhu et al. · 2025 · Nucleic Acids Research
59. DSA-DeepFM: a dual-stage attention-enhanced DeepFM model for predicting anticancer synergistic drug combinations
    Yuexi Gu, Yongheng Sun, Louxin Zhang, Jian Zu · 2024 · Bioinformatics Advances
60. WEE1 inhibition delays resistance to CDK4/6 inhibitor and antiestrogen treatment in ER+ MCF7 cells
    Wei He, Diane M. Demas, Pavel Kraikivski, Ayesha N. Shajahan‐Haq, William T. Baumann · 2025 · npj Systems Biology and Applications
61. Multimodal Hypergraph Representation Learning for Drug Synergy Prediction
    Zheng Zhang, Tong Luo, Xian-Gan CHEN, Xiaofei Yang, Jihong Gong · 2025 · IEEE Transactions on Computational Biology and Bioinformatics
62. Carbon Nanotubes and Graphene in Breast Cancer Theragnostics
    Murat Torun, Nursel Pekel Bayramgil · 2026 · Springer eBooks
63. A Comprehensive Review on Applications of Polylactic Acid in Novel Drug Delivery System
    Krishna Bhagwan Bharti, Pranoti Sunil Mohod, Raksha Laxman Mhetre, Shashikant Nivrutti Dhole, Nandan Kulkarni · 2025 · Biosciences Biotechnology Research Asia
64. Characterizing clinical toxicity in cancer combination therapies
    Alexandra M. Wong, Cecile P. G. Meier-Scherling, Lorin A. Crawford · 2026 · Bioinformatics
65. Buddlejasaponin IV inhibits proliferation and migration via STAT3 suppression in gefitinib-resistant non-small cell lung cancer cells
    Sung Chul Jang, Donghwa Kim, Jaeho Han, Dong Hyun Moon, Eun Seo Bae, Chae Won Ock, Hyen Joo Park, Sang Kook Lee · 2026 · BMC Complementary Medicine and Therapies
66. Evaluation of TRAM@PPF Nanoparticles for Efficacy Against Pancreatic Cancer in Mice Model
    Ping Sheng, Liang Zhang, Wenwei Xie, Yu He, Yanjiao Wu, Jinyu Huang, D. Li, Jiafu Leng, Debing Xiang · 2026 · International Journal of Nanomedicine
67. Copper (I) nicotinate complex potentiates chemotherapy-induced apoptosis in HCC-1806 triple negative breast cancer cells: An in vitro study
    Marihan A. Helal, MOHAMED A. ABDEL-MOHSEN, Elshahat A. Toson · 2026 · Journal of Inorganic Biochemistry
68. Integrating multi-omics data for next-generation cancer research and precision medicine
    Soham Biswas, Sovon Acharya, Anjali Prajapat, Poonam Sen, Shailesh Desai, Shatrunjai Giri, Rune Matthiesen, The CAPCI, Gyaneshwer Chaubey, Prashanth Suravajhala · 2026 · Clinical & Translational Oncology
69. Metabolic Activation‐Dependent Anti‐Liver Cancer Activity and Organ‐Specific Toxicity of Retrorsine From Fanhuncao ( Jacobaea cannabifolia and J. litvinovii )
    Zhijie He, Zhongyu Tan, Lunrong Zhang, Yue Yin, Yedeli Yerjiang, Bo Bi, Jingshan Bao · 2026 · Archiv der Pharmazie
70. High-throughput print-to-screen (P2S) platform for combinatorial chemotherapy
    Jiannan Li, Yunfeng Ding, Wenwu Xiao, Kai Xiao, Ji Yae Lee, U. Bhardwaj, Zijie Zhu, Philip Digiglio, Kit S. Lam, Tingrui Pan · 2015 · International Conference on Solid-State Sensors, Actuators and Microsystems
71. From Bench to Bedside with Targeted Therapies
    John M. Mendelsohn · 2015 · Elsevier eBooks
72. Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug
    Resistance de Castro, Paul Andrew Clarke, Bissan Al‐Lazikani, Paul Workman · 2013
73. Drug combination and nanooncology for improvement in the treatment of breast cancer: a review
    Raquel Santos Faria, Danielle Galdino de Souza, Thyago José Arruda Pacheco, Franciéle de Matos da Silva, Victor Carlos Mello da Silva, Luíza Ianny de Lima · 2021 · Research Society and Development
74. Onkologika
    Wolf-Dieter Ludwig, U. Schwabe · 2017 · Springer eBooks
75. Onkologika
    Wolf-Dieter Ludwig, U. Schwabe · 2018 · Springer eBooks
76. Onkologika
    Wolf-Dieter Ludwig, U. Schwabe · 2016 · Springer eBooks
77. DSCN: Double-target selection guided by CRISPR screening and network
    Enze Liu, Xue Wu, Lei Wang, Yang Huo, Huanmei Wu, Lang Li, Lijun Cheng · 2022 · PLoS Computational Biology
78. Pairwise synthetic cytotoxicity between Paxlovid and 100 frequently prescribed FDA-approved small molecule drugs on liver cells
    Zara Ahmad Khan, Yuli Hu, Behafarid Ghalandari, Mashaal Ahmad, Aynur Abdullah, Lai Jiang, Xianting Ding · 2023 · Toxicology and Applied Pharmacology
79. Functional exploration of copy number alterations in a Drosophila model of triple-negative breast cancer
    Jennifer E. L. Diaz, Vanessa Barcessat, Christian Bahamon, Chana Hecht, Tirtha K. Das, Ross Leigh Cagan · 2024 · Disease Models & Mechanisms
80. scCADE: A Superior Tool for Predicting Perturbation Responses in Single-Cell Gene Expression Using Contrastive Learning and Attention Mechanisms
    Jingfeng Ou, Jiawei Li, Zhiliang Xia, Shurui Dai, Yulian Ding, Yan Ping Guo, Limin Jiang, Jijun Tang · 2024 · IEEE International Conference on Bioinformatics and Biomedicine (BIBM)
81. PartialFibers: An Efficient Method for Predicting Drug-Drug Interactions
    Aysegul Bumin, Kejun Huang, Tamer Kahveci · 2025 · Lecture notes in computer science
82. Progress in Biomimetic Microdevices for Anticancer Drug Screening and their Potential for Enhancing In Vivo Efficacy
    Ching‐Te Kuo, Yen‐Tzu Liao, Hsinyu Lee · 2025 · Advanced NanoBiomed Research
83. Quinaldehyde o-Nitrobenzoylhydrazone: Structure and Sensitization of HepG2 Cells to Anti-Cancer Drugs
    Valeri V. Mossine, Steven P. Kelley, Thomas Patrick Mawhinney · 2025 · Compounds
84. Using Systems Pharmacology to Advance Oncology Drug Development
    Daniel C. Kirouac · 2016 · AAPS advances in the pharmaceutical sciences series
85. Crocetin as an Active Secondary Metabolite of Saffron Stigma and Anticancer Effects
    Ali Farahi, Homa Mollaei, Reyhane Hoshyar · 2018 · Current Cancer Therapy Reviews
86. One-Step Generation of a Drug-Releasing Microarray for High-Throughput Small-Volume Bioassays
    Seo Woo Song · 2019 · Springer theses
87. Inferring perturbation profiles of cancer samples
    Martin Pirkl, Niko Beerenwinkel · 2021 · Bioinformatics
88. usEPs in Pre-clinical Cancer Treatment
    Stephen J. Beebe · 2021 · Series in bioengineering
89. Multifunctional Nanotherapeutics for Drug-Resistant Breast Cancer
    Song Lou · 2022 · Bioequivalence & Bioavailability International Journal
90. Precision Medicine, Imprecise Health Care Justice
    Leonard Michael Fleck · 2022 · Oxford University Press eBooks
91. Recent advancements in sodium alginate-based nanogels
    Soha Mubeen, Asma Asif, Awais Ahmad, Mariam Khan · 2023 · Elsevier eBooks
92. Network-Based Molecular Features Selection to Predict the Drug Synergy in Cancer Cells
    Syarifah Aini, Wisnu Ananta Kusuma, Medria Kusuma Dewi Hardhienata, Mushthofa · 2023 · Journal of Electronics Electromedical Engineering and Medical Informatics
93. Antimicrobial Synergism within Plant Extract Combinations
    Ali Abdallah Alqudah · 2023 · Pharmaceutical Drug Regulatory Affairs Journal
94. Quantum Dots' Role in Cancer Diagnosis: An overview on NanoFluorescence in Oncology
    Redouane En‐nadir · 2023 · Nanomedicine & Nanotechnology Open Access
95. Protein Kinases and Caspases: Bidirectional Interactions in Apoptosis
    Stephanie A. Zukowski, David W. Litchfield · 2015 · Wiley eBooks
96. Integrated Computational and Experimental Approaches for Accelerated Drug Combination Discovery and Development : Applications in Cancer Pharmacology
    Muhammad Kashif · 2015 · Uppsala University Publications (Uppsala University)
97. Transitions in interaction landscapes of multidrug combinations
    Tina Manzhu Kang, Bjørn Østman, Mauricio Cruz‐Loya, Natalie Ann Lozano-Huntelman, Robert D. Damoiseaux, Van M. Savage, Pamela J. Yeh · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
98. Progress in the Systemic Management of Advanced Prostate Cancer: The Hormone-Sensitive Paradigm
    Channing Judith Paller, Mario A. Eisenberger · 2019 · Journal of Clinical Oncology
99. Dichloroacetate and PX-478 Exhibit Strong Synergistic Effects in a Various Number of Cancer Cell Lines.
    Jonas Parczyk, Jérôme Ruhnau, Carsten Pelz, Max Schilling, Hao Wu, Nicole Nadine Piaskowski, Britta Johanna Eickholt, Hartmut Kühn, Kerstin Danker, Andreas Klein · 2020 · Research Square
100. Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in KRAS -Mutant Cancers
     Daniel P. Nussbaum, Colin A. Martz, Andrew M. Waters, Alejandro Barrera, Justine C. Rutter, Christian G. Cerda-Smith, Amy E. Stewart, Chao Wu, Merve Çakır, Cecilia Blair Levandowski et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)